These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 145049)

  • 61. Polymyalgia rheumatica and giant cell arteritis.
    Myles AB
    BMJ; 1995 Nov; 311(7014):1232. PubMed ID: 7488934
    [No Abstract]   [Full Text] [Related]  

  • 62. Bone changes during prednisone treatment.
    Deding A; Tougaard L; Krogh Jensen M; Rodbro P
    Acta Med Scand; 1977; 202(4):253-5. PubMed ID: 562590
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The use of dapsone in the treatment of giant cell arteritis and polymyalgia rheumatica.
    Doury P; Pattin S; Eulry F; Thabaut A
    Arthritis Rheum; 1983 May; 26(5):689-90. PubMed ID: 6847733
    [No Abstract]   [Full Text] [Related]  

  • 64. A district audit on the management of polymyalgia rheumatica and giant cell arteritis.
    Myles AB
    Br J Rheumatol; 1994 Jul; 33(7):690. PubMed ID: 8019805
    [No Abstract]   [Full Text] [Related]  

  • 65. Stopping steroids in polymyalgia rheumatica and giant cell arteritis.
    Kyle V; Hazelman BL
    BMJ; 1990 Feb; 300(6721):344-5. PubMed ID: 2106980
    [No Abstract]   [Full Text] [Related]  

  • 66. Treatment of polymyalgia rheumatica.
    Spiera H; Davison S
    Arthritis Rheum; 1982 Jan; 25(1):120. PubMed ID: 7066032
    [No Abstract]   [Full Text] [Related]  

  • 67. Long-term follow-up of polymyalgia rheumatica.
    Spiera H; Davison S
    Mt Sinai J Med; 1978; 45(2):225-9. PubMed ID: 96334
    [No Abstract]   [Full Text] [Related]  

  • 68. Polymyalgia rheumatica. Duration of therapy and long-term outcome.
    Ayoub WT; Franklin CM; Torretti D
    Am J Med; 1985 Sep; 79(3):309-15. PubMed ID: 4036982
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Summaries for patients. Adding infliximab to the treatment regimen for polymyalgia rheumatica.
    Ann Intern Med; 2007 May; 146(9):I20. PubMed ID: 17470827
    [No Abstract]   [Full Text] [Related]  

  • 70. Summaries for patients. Prednisone plus methotrexate for polymyalgia rheumatica.
    Ann Intern Med; 2004 Oct; 141(7):I12. PubMed ID: 15466761
    [No Abstract]   [Full Text] [Related]  

  • 71. [Treatment of Horton's disease and rhizomelic pseudopolyarthritis with dapsone. Preliminary results].
    Doury P; Pattin S; Eulry F; Maurel C; Masson C; Tabaraud F
    Presse Med; 1983 Jan; 12(2):104. PubMed ID: 6221313
    [No Abstract]   [Full Text] [Related]  

  • 72. [Bilateral acute arteritic anterior ischemic optic neuropathy during chronic steroid therapy].
    Herbaut A; Qu-Knafo L; Abad S; Dhote R; Giocanti-Aurégan A
    J Fr Ophtalmol; 2017 Sep; 40(7):e249-e251. PubMed ID: 28801036
    [No Abstract]   [Full Text] [Related]  

  • 73. [Horton disease and rhizomelic pseudopolyarthritis: novel therapies? Follow-up and prognosis].
    Duhaut P
    Rev Med Interne; 2008 Dec; 29 Suppl 3():S281-5. PubMed ID: 18992970
    [No Abstract]   [Full Text] [Related]  

  • 74. Giant cell arteritis--the need for prolonged treatment.
    Beevers DG; Harpur JE; Turk KA
    J Chronic Dis; 1973 Sep; 26(9):571-84. PubMed ID: 4202423
    [No Abstract]   [Full Text] [Related]  

  • 75. [Therapeutic approach for systemic diseases in the elderly. Horton disease and rhizomelic pseudopolyarthritis].
    Doucet J
    Rev Med Interne; 2008 Dec; 29 Suppl 3():S289-93. PubMed ID: 18996628
    [No Abstract]   [Full Text] [Related]  

  • 76. Trigeminal herpes zoster causing mandibular osteonecrosis and spontaneous tooth exfoliation.
    Manz HJ; Canter HG; Melton J
    South Med J; 1986 Aug; 79(8):1026-8. PubMed ID: 3738577
    [TBL] [Abstract][Full Text] [Related]  

  • 77. New therapeutic targets in giant-cell arteritis. Considerations based on the current pathogenic model and the availability of new therapeutic agents.
    Lozano E; Segarra M; García-Martínez A; Espígol-Frigolé G; Hernández-Rodríguez J; Cid MC
    Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S141-50. PubMed ID: 18799072
    [No Abstract]   [Full Text] [Related]  

  • 78. Role of gluten, prednisone, and azathioprine in non-responsive coeliac disease.
    Hamilton JD; Chambers RA; Wynn-Williams A
    Lancet; 1976 Jun; 1(7971):1213-6. PubMed ID: 58260
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prednisone effect on microvascular permeability in patients with inflammatory rheumatic diseases.
    Manthorpe R; Hansen TM; Junker P; Lorenzen I; Utne HE
    Scand J Rheumatol; 1979; 8(3):139-41. PubMed ID: 40306
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Another look at corticotrophin therapy: clinical and biochemical assessment.
    Thorpe P
    Med J Aust; 1969 Feb; 1(8):387-90. PubMed ID: 4305679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.